Coherus BioSciences Inc (NASDAQ:CHRS)

9.55
Delayed Data
As of 4:00pm ET
 +0.40 / +4.37%
Today’s Change
8.05
Today|||52-Week Range
26.55
+8.52%
Year-to-Date
No recent news for Coherus BioSciences Inc.

Today’s Trading

Previous close9.15
Today’s open9.25
Day’s range9.05 - 9.65
Volume343,552
Average volume (3 months)594,885
Market cap$547.5M
Data as of 4:00pm ET, 02/23/2018

Growth & Valuation

Earnings growth (last year)+49.42%
Earnings growth (this year)-47.47%
Earnings growth (next 5 years)--
Revenue growth (last year)+532.82%
P/E ratioNM
Price/Sales6.21
Price/Book20.42

Competitors

 Today’s
change
Today’s
% change
IMGNImmunoGen Inc+0.33+3.04%
NTLAIntellia Therapeutic...+0.55+2.15%
MYOVMyovant Sciences Ltd-0.03-0.21%
ADAPAdaptimmune Therapeu...+0.23+3.01%
Data as of 4:02pm ET, 02/23/2018

Financials

Last reporting date--
EPS forecast (this quarter)-$0.88
Annual revenue (last year)$190.1M
Annual profit (last year)-$127.3M
Net profit margin-66.98%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Denny M. Lanfear
Chief Financial Officer
Jean-Frédéric Viret
Corporate headquarters
Redwood City, California

Forecasts